ARTN was found to promote metastasis and poor survival outcome in patients with estrogen receptor (ER) negative mammary carcinoma (ER‐MC) via its cooperation with twist family BHLH transcription factor 1 (TWIST1). The gene discussed is TWIST1; the disease is breast carcinoma.